Best Non-GLP-1 Weight Loss Alternatives in New York
Physician-supervised non-GLP-1 weight loss treatment through NewYorkDoc. Start a visit to see if treatment is appropriate. A patient in New York City, Buffalo, Rochester, and Albany should compare non-GLP-1 weight loss treatment with care already available through NewYork-Presbyterian, Mount Sinai, or NYU Langone, not with a New Jersey clinic across the Hudson or a Pennsylvania clinic from the Southern Tier.
Treatment options
Metformin
Often used when insulin resistance is part of the picture. Physician-supervised dosing and lab follow-up.
Learn MoreNaltrexone-bupropion
Combination therapy that can support appetite control when clinically appropriate.
Learn MoreTopiramate-based plans
Considered when other options are not suitable. Requires medical screening for contraindications.
Start VisitLifestyle-supported plan
Nutrition and follow-up support alongside medication when a GLP-1 is not indicated.
Explore OptionsWhat Best Non-GLP-1 Weight Loss Alternatives in New York is
Not every patient is a candidate for GLP-1 therapy. Non-GLP-1 options can include metformin, topiramate, naltrexone-bupropion, and other physician-directed plans when GLP-1 is not the right fit.
Who this is for in New York
Adults who cannot use GLP-1 medications, prefer a different approach, or need an alternative after a GLP-1 trial can be evaluated for these options.
The patients this page is for live in New York City, Buffalo, Rochester, and Albany.
How the NewYorkDoc visit works
The NewYorkDoc visit starts with a structured intake covering symptoms, medications, allergies, and prior treatment response. A New York-licensed physician (NY) reviews whether non-GLP-1 weight loss treatment is appropriate, whether labs are required, and whether another approach is safer. If a prescription is indicated, it is sent to a pharmacy the patient can use in New York. That prescription is not a referral to a New Jersey clinic across the Hudson or a Pennsylvania clinic from the Southern Tier.
Follow-up is scheduled when treatment starts. Chronic therapies are commonly rechecked at about four weeks, then every one to three months, or sooner if side effects appear.
What happens next
If you want to know whether non-GLP-1 weight loss treatment is appropriate, start a visit. You will leave with a clear yes, a different plan, or a referral. NewYorkDoc does not guarantee a prescription.
Local access
A patient in New York City, Buffalo, Rochester, and Albany should compare non-GLP-1 weight loss treatment with care already available through NewYork-Presbyterian, Mount Sinai, or NYU Langone, not with a New Jersey clinic across the Hudson or a Pennsylvania clinic from the Southern Tier. Labs, when needed, can be drawn through a local partner in New York.